---
title: Double Trouble for Cancer Tumors
tags:
  - Cancer Immunotherapy
  - PD-1 inhibitors
  - Cancer Therapy
  - PTPN2
author: Hossein Fallahi
member: Hossein Fallahi
---
Cancer immunotherapy drugs called PD-1 inhibitors are widely used to stimulate the immune system to fight cancer, but many patients either donâ€™t respond or develop resistance to them. 
A new small-molecule drug candidate being tested in an early-stage clinical trial aims to improve patient responses to immunotherapy. Check the [paper](https://www.nature.com/articles/s41586-023-06575-7#auth-Hakimeh-Ebrahimi_Nik-Aff2-Aff3-Aff7) in Nature.
